If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Robert E. Farrell, Jr. net worth and biography

Robert Farrell, Jr. Biography and Net Worth

CAO of Morphic

Robert E. Farrell Jr., CPA is the Senior Vice President of Finance/Operations and Chief Accounting Officer at Morphic Therapeutic Inc. and was part of the initial company formation in June 2015. Prior to joining Morphic Therapeutic, he served as Vice President of Finance and Administration and Treasurer of Genocea Biosciences from 2009 to 2015. Before that, he held senior level financial positions at Oscient Pharmaceuticals, Magen Biosciences and NeoGenesis Pharmaceuticals, Inc., where he directed companies through multiple private financings, acquisitions and several public offerings. Mr. Farrell is a licensed certified public accountant and holds a B.S. degree in accounting from Bentley University.

What is Robert E. Farrell, Jr.'s net worth?: The estimated net worth of Robert E. Farrell, Jr. is at least $1.41 million as of May 23rd, 2023. Mr. Farrell, Jr. owns 23,708 shares of Morphic stock worth more than $1,409,204 as of June 7th. This net worth estimate does not reflect any other investments that Mr. Farrell, Jr. may own. Learn More about Robert E. Farrell, Jr.'s net worth.
How do I contact Robert E. Farrell, Jr.?: The corporate mailing address for Mr. Farrell, Jr. and other Morphic executives is 35 Gatehouse Drive A2, Waltham MA, 02451. Morphic can also be reached via phone at (781) 996-0955. Learn More on Robert E. Farrell, Jr.'s contact information.
Has Robert E. Farrell, Jr. been buying or selling shares of Morphic?: During the past quarter, Robert E. Farrell, Jr. has sold $2,422,100.00 in shares of Morphic stock. Most recently, Robert E. Farrell, Jr. sold 10,000 shares of the business's stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $60.00, for a transaction totalling $600,000.00. Following the completion of the sale, the chief accounting officer now directly owns 23,708 shares of the company's stock, valued at $1,422,480. Learn More on Robert E. Farrell, Jr.'s trading history.
Who are Morphic's active insiders?: Morphic's insider roster includes Robert Farrell, Jr. (CAO), Peter Linde (Insider), Bruce Rogers (Insider), Marc Schegerin (CFO), and Timothy Springer (Director). Learn More on Morphic's active insiders.
Are insiders buying or selling shares of Morphic?: During the last twelve months, Morphic insiders bought shares 1 times. They purchased a total of 1,050,000 shares worth more than $47,250,000.00. During the last twelve months, insiders at the sold shares 18 times. They sold a total of 246,067 shares worth more than $12,079,159.87. The most recent insider tranaction occured on June, 1st when CEO Praveen P Tipirneni sold 3,597 shares worth more than $205,532.58. Insiders at Morphic own 28.1% of the company. Learn More about insider trades at Morphic.
Information on this page was last updated on 6/1/2023.

Robert E. Farrell, Jr. Insider Trading History at Morphic

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/23/2023	Sell	10,000	$60.00	$600,000.00	23,708
4/25/2023	Sell	10,000	$54.71	$547,100.00	12,222
4/20/2023	Sell	10,000	$45.00	$450,000.00	12,222
4/17/2023	Sell	20,000	$41.25	$825,000.00	2,222
1/14/2023	Sell	1,248	$30.63	$38,226.24	22,222
9/13/2021	Sell	3,049	$65.01	$198,215.49
9/10/2021	Sell	9,859	$65.14	$642,215.26	22,908
6/18/2021	Sell	200	$65.00	$13,000.00	18,234
6/16/2021	Sell	300	$65.00	$19,500.00	18,234
6/14/2021	Sell	3,526	$65.00	$229,190.00	33,934
6/10/2021	Sell	16,000	$60.08	$961,280.00	33,934
2/3/2021	Sell	25,000	$37.28	$932,000.00
12/30/2020	Sell	7,364	$32.56	$239,771.84	35,703
12/28/2020	Sell	12,636	$32.31	$408,269.16	35,703
11/9/2020	Sell	800	$28.00	$22,400.00	52,974
10/26/2020	Sell	1,760	$28.23	$49,684.80	55,534
10/23/2020	Sell	2,300	$28.31	$65,113.00	55,534
10/12/2020	Sell	1,149	$27.02	$31,045.98	59,083
10/8/2020	Sell	9,814	$26.24	$257,519.36	69,598
10/5/2020	Sell	2,000	$26.56	$53,120.00	74,655
10/1/2020	Sell	3,279	$27.61	$90,533.19	74,655
6/1/2020	Sell	6,681	$20.35	$135,958.35	84,615
5/29/2020	Sell	13,319	$20.17	$268,644.23	84,615

Robert E. Farrell, Jr. Buying and Selling Activity at Morphic

Morphic Company Overview

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Today's Range

Now: $61.57

$59.12

$61.87

50 Day Range

MA: $48.67

$34.33

$59.50

2 Week Range

Now: $61.57

$19.23

$61.87

Volume

678,737 shs

Average Volume

488,951 shs

Market Capitalization

$2.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Yours Free! Top FIVE Dividend Stocks Right Now

From The Oxford Club | Ad

This Ultimate Dividend Package contains an "A"-rated, ultra-safe dividend stock with a huge 8% yield, and one income expert's No. 1 dividend stock for a LIFETIME of income.

Click here to get your FREE Ultimate Dividend Package.

>>>